DrugPatentWatch Database Preview
Details for New Drug Application (NDA): 078314
The generic ingredient in NAPROXEN SODIUM is naproxen sodium; pseudoephedrine hydrochloride. There are forty-two drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the naproxen sodium; pseudoephedrine hydrochloride profile page.
Summary for 078314
Tradename: | NAPROXEN SODIUM |
Applicant: | Glenmark Pharms Ltd |
Ingredient: | naproxen sodium |
Patents: | 0 |
Therapeutic Class: | Analgesics Anti-inflammatory Agents |
Formulation / Manufacturing: | see details |
Pharmacology for NDA: 078314
Ingredient-type | Nonsteroidal Anti-inflammatory Compounds |
Mechanism of Action | Cyclooxygenase Inhibitors |
Suppliers and Packaging for NDA: 078314
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
NAPROXEN SODIUM | naproxen sodium | TABLET;ORAL | 078314 | ANDA | Blenheim Pharmacal, Inc. | 10544-063 | E | 10544-063-20 |
NAPROXEN SODIUM | naproxen sodium | TABLET;ORAL | 078314 | ANDA | Blenheim Pharmacal, Inc. | 10544-275 | E | 10544-275-15 |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | EQ 250MG BASE | ||||
Approval Date: | Apr 27, 2007 | TE: | AB | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | EQ 500MG BASE | ||||
Approval Date: | Apr 27, 2007 | TE: | AB | RLD: | No |
Complete Access Available with Subscription